Homologous recombination deficiency (HRD) activates pro-inflammatory cGAS/STING signaling, positioning it as a biomarker for combining immune checkpoint blockade (ICB) and PARP inhibition (PARPi). Here, STING1 is linked to hypoparathyroidism-retardation-dysmorphism syndrome.